Global Digital Pathology Market is expected to reach USD 692.5 million by 2022. Increasing automation in the field of in vitro diagnostics especially pertaining to pathology is expected to drive the growth of the digital pathology market over the forecast period. Growing prevalence of chronic diseases such as cancer is further expected to heighten the demand for faster and accurate diagnostic tools. Growth in the penetration rates of EHR in the North American and European regions is also likely to have a positive impact on market growth over the forecast period. Inherent advantages associated with digital pathology systems are expected to boost usage rates. Consumers are expected to initiate the use of digital pathology systems in an attempt to curb costs, render improved patient care, improve workflow system and minimize human error related incidences.
Whole slide imaging is expected to grow at a lucrative rate. The technology renders high resolution digital images with multiple magnifications in a shorter period of time and this is expected to promote usage rates over the forecast period.
Browse Full Research Report With TOC On "Digital Pathology Market Size, Report, 2022" at: http://www.radiantinsights.com/research/digital-pathology-market-analysis-by-technology-whole-slide-imaging-telepathology-static-dynamic-by-application-disease-diagnosis-academics-drug-discovery-amp-development-and-segment-forecasts-to-2022
Further key findings from the study suggest:
- Digital pathology services found the largest application in disease diagnosis in 2014. Increasing prevalence of cancer & other chronic diseases heightening the demand for accurate and faster diagnostic tools and greater applicability are some factors accounting for its large share.
- North America was the most matured regional digital pathology market in 2014 and accounted for over 40.0% of revenue. Presence of sophisticated healthcare infrastructure favoring the implementation of electronic medical records and growing demand for device automation is some factors responsible for its large share.
- Asia Pacific region on account of the presence of large untapped opportunities, rapidly improving healthcare infrastructure and increasing usage of digital pathology in academics and research is expected to provide this market with lucrative future growth opportunities.
- Some key players of digital pathology services include GE Healthcare, 3DHistech Inc., Leica Biosystems, Ventana Medical Systems, Inc., Philips Healthcare, Definiens, Olympus Corporation, Omynx LLC, Objective Pathology Services, LigoLAb LLC, Hamamatsu Photonics Inc., and MicroSkan Technologies.
- Providing technologically advanced pathological systems & services and capitalizing on the untapped opportunities via strategic collaborations are some key strategic moves adopted by these market players.
Browse All Reports of This Category at: www.radiantinsights.com/catalog/medical-devices
Global Digital Pathology Technology Outlook (Revenue, USD Million, 2012 - 2022)
- Whole slide Imaging
- Telepathology
- Static
- Dynamic
Global Digital Pathology Application Outlook (Revenue, USD Million, 2012 - 2022)
- Drug Discovery & Development
- Academic
- Disease Diagnosis
Digital Pathology Regional Outlook (Revenue, USD Billion, 2012 - 2022)
- North America
- S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
Related Reports by Radiant Insights:
- Global Bariatric Surgery Devices Market –
http://www.radiantinsights.com/research/global-bariatric-surgery-devices-market-2014-2018
- Global Pancreatic Cancer Market –
http://www.radiantinsights.com/research/global-pancreatic-cancer-market-2014-2018


Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 



